For emerging growth companies who are setting their stock option strike prices or valuing the options themselves, we provide independent valuation opinions backed by extensive experience. Our team has valued a wide range of high-growth, early-stage firms, including but not limited to bio-tech and high-tech, software, new media, e-commerce and telecommunications, among others. We also develop option-related valuations for more established businesses as they approach various liquidity events, including potential IPOs.

Restricted stock (Rule 144) and shares that are subject to lock-up or performance agreements frequently require valuations for gifting, financial reporting or matrimonial actions. There are many cases where lock-up restrictions may impact the value paid for an acquisition. We help ensure that clients do not over-report the value of these securities, or the price paid for an acquisition, in either a financial or tax reporting environment.

KEY CONTACTS

Scott Brace, ASA
Boston: 617.535.7785
Rochester: 585.475.9260
sbrace@empireval.com


Chuck Coyne, ASA
Boston: 617.535.7785
West Hartford: 860.233.6552
ccoyne@empireval.com


Kevin Kane, CFA, ASA
Rochester: 585.475.9260
San Francisco: 415.659.1860
kkane@empireval.com


Hugh Woodside, ASA, CFA
Boston: 617.535.7785
Rochester: 585.794.5720
hwoodside@empireval.com

 

 

  LinkedIn Logo   TwitterLogo   FacebookLogo